Laura Sutcliffe
Stock Analyst at UBS
(1.58)
# 1470
Out of 5,344 analysts
8
Total ratings
80.00%
Success rate
13.17%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RMD ResMed | Maintains: Buy | 290 285 | 243.18 | 17.2% | 1 | Apr 24, 2025 | |
TLX Telix Pharmaceutical... | Maintains: Strong Buy | 21 22 | 16.57 | 32.77% | 2 | Jan 27, 2025 | |
UCBJY UCB | Upgrades: Buy | n/a | n/a | n/a | 1 | Aug 23, 2021 | |
ARGX argenx | Initiates Coverage On: Buy | 390 | 588.14 | -33.69% | 1 | Jun 18, 2021 | |
GNHAF Vifor Pharma AG | Upgrades: Neutral | n/a | n/a | n/a | 1 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Dec 20, 2019 |